Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W E Ross

Showing results (11-20 of 60) with videos related to

Pageof 6
Sort By:
Anti-Cancer Drug Design|October 1, 1987
DNA topoisomerases in cancer therapyR B Lock, W E Ross
Cancer Treatment and Research|January 1, 1991
Resistance to inhibitors of DNA topoisomerasesD M Sullivan, W E Ross
Cancer Research|June 15, 1990
Inhibition of p34cdc2 kinase activity by etoposide or irradiation as a mechanism of G2 arrest in Chinese hamster ovary cellsR B Lock, W E Ross
Veterinary Surgery : VS|January 1, 1993
Evaluation of an omental pedicle extension technique in the dogW E Ross, A D Pardo
The Journal of the Florida Medical Association|March 1, 1994
Medical schools on the fault lineW E Ross, A H Neims
Pharmacology & Therapeutics|January 1, 1987
DNA topoisomerase II: a primer on the enzyme and its unique role as a multidrug target in cancer chemotherapyB S Glisson, W E Ross
Molecular and Cellular Biology|September 1, 1987
Topoisomerase-specific drug sensitivity in relation to cell cycle progressionK C Chow, W E Ross
Biochimica Et Biophysica Acta|June 26, 1981
DNA double-stranded breaks in mammalian cells after exposure to intercalating agentsW E Ross, M O Bradley
Cancer Research|August 1, 1984
Potentiation of etoposide-induced DNA damage by calcium antagonists in L1210 cells in vitroJ C Yalowich, W E Ross
Cancer Research|January 1, 1983
DNA damage as a basis for 4'-demethylepipodophyllotoxin-9-(4,6-O-ethylidene-beta-D-glucopyranoside) (etoposide) cytotoxicityA J Wozniak, W E Ross
Pageof 6

Showing results (11-20 of 60) with videos related to

Sort By:
Pageof 6
Anti-Cancer Drug Design|October 1, 1987
DNA topoisomerases in cancer therapyR B Lock, W E Ross
Cancer Treatment and Research|January 1, 1991
Resistance to inhibitors of DNA topoisomerasesD M Sullivan, W E Ross
Cancer Research|June 15, 1990
Inhibition of p34cdc2 kinase activity by etoposide or irradiation as a mechanism of G2 arrest in Chinese hamster ovary cellsR B Lock, W E Ross
Veterinary Surgery : VS|January 1, 1993
Evaluation of an omental pedicle extension technique in the dogW E Ross, A D Pardo
The Journal of the Florida Medical Association|March 1, 1994
Medical schools on the fault lineW E Ross, A H Neims
Pharmacology & Therapeutics|January 1, 1987
DNA topoisomerase II: a primer on the enzyme and its unique role as a multidrug target in cancer chemotherapyB S Glisson, W E Ross
Molecular and Cellular Biology|September 1, 1987
Topoisomerase-specific drug sensitivity in relation to cell cycle progressionK C Chow, W E Ross
Biochimica Et Biophysica Acta|June 26, 1981
DNA double-stranded breaks in mammalian cells after exposure to intercalating agentsW E Ross, M O Bradley
Cancer Research|August 1, 1984
Potentiation of etoposide-induced DNA damage by calcium antagonists in L1210 cells in vitroJ C Yalowich, W E Ross
Cancer Research|January 1, 1983
DNA damage as a basis for 4'-demethylepipodophyllotoxin-9-(4,6-O-ethylidene-beta-D-glucopyranoside) (etoposide) cytotoxicityA J Wozniak, W E Ross
Pageof 6